1. Chlormadinone, nomegestrol: measures needed to minimise risk of meningioma

   News item 23 July 2022 Pages: 1 - 1

2. Citalopram, escitalopram, risk of dose-dependent QT-interval prolongation

   News item 23 July 2022 Pages: 2 - 2

3. Dosing errors common with Paxlovid

   News item 23 July 2022 Pages: 3 - 3

4. Safety warning by NZ Medsafe for Nhan Sam Tuyet Lien Truy Phong Hoan

   News item 23 July 2022 Pages: 4 - 4

5. US FDA warning about honey-based products with hidden prescription-drug ingredients

   News item 23 July 2022 Pages: 5 - 5

6. Assessing safety profile of mass praziquantel and albendazole administration in Rwanda

   Clinical study 23 July 2022 Pages: 6 - 6

7. Autoantibody positivity predicts severity of ICI-associated rheumatic immune-related adverse events

   Clinical study 23 July 2022 Pages: 7 - 7

8. Combined nivolumab + ipilimumab in cancer treatment: high risk of adverse events

   Clinical study 23 July 2022 Pages: 8 - 8

9. Drug interaction safety signals for tizanidine identified

   Clinical study 23 July 2022 Pages: 9 - 9

10. New potential safety signals for CAR-T cell therapies

    Clinical study 23 July 2022 Pages: 10 - 10

11. Targeted therapies for RCC: high risk of MACE

    Clinical study 23 July 2022 Pages: 11 - 11

12. Treatment of M. avium complex pulmonary disease: more ADRs and worse outcomes with age

    Clinical study 23 July 2022 Pages: 12 - 12

13. Other adverse reaction research

    News item 23 July 2022 Pages: 13 - 13

14. Acetylcysteine/bicarbonate/glucocorticoids

    Case report 23 July 2022 Pages: 14 - 14

15. Acetylcysteine/primidone

    Case report 23 July 2022 Pages: 15 - 15

16. Aciclovir/piperacillin/tazobactam

    Case report 23 July 2022 Pages: 16 - 16

17. Ad26.COV2-S

    Case report 23 July 2022 Pages: 17 - 17

18. Ad26.COV2-S/AZD-1222

    Case report 23 July 2022 Pages: 18 - 18

19. Adalimumab

    Case report 23 July 2022 Pages: 19 - 19

20. Adalimumab/methotrexate/secukinumab

    Case report 23 July 2022 Pages: 20 - 20

21. Adalimumab/prednisolone/corticosteroids

    Case report 23 July 2022 Pages: 21 - 21

22. Albumin-human/norepinephrine/phenylephrine

    Case report 23 July 2022 Pages: 22 - 22

23. Allopurinol/fosfomycin/gabapentin

    Case report 23 July 2022 Pages: 23 - 23

24. Alpha-1-antitrypsin/methylprednisolone

    Case report 23 July 2022 Pages: 24 - 24

25. Alprazolam/baclofen misuse/overdose

    Case report 23 July 2022 Pages: 25 - 25

26. Amikacin/botulinum-toxin

    Case report 23 July 2022 Pages: 26 - 26

27. Amoxicillin

    Case report 23 July 2022 Pages: 27 - 27

28. Amoxicillin/amoxicillin/clavulanic-acid

    Case report 23 July 2022 Pages: 28 - 28

29. Amphotericin-b

    Case report 23 July 2022 Pages: 29 - 29

30. Amphotericin-b-liposomal

    Case report 23 July 2022 Pages: 30 - 30

31. Amphotericin-B/prednisolone-acetate

    Case report 23 July 2022 Pages: 31 - 31

32. Anti-inflammatories/pamidronic-acid

    Case report 23 July 2022 Pages: 32 - 32

33. Antibacterials

    Case report 23 July 2022 Pages: 33 - 33

34. Antibacterials/contraceptives

    Case report 23 July 2022 Pages: 34 - 34

35. Antibacterials/corticosteroids

    Case report 23 July 2022 Pages: 35 - 36

36. Antibacterials/dexamethasone/prednisone

    Case report 23 July 2022 Pages: 36 - 36

37. Antibacterials/lactobacillus-acidophilus/lactobacillus-casei/lactobacillus-paracasei/lactobacillus-plantarum/lactobacillus-rhamnosus/lactobacillus-salivarius/prednisone

    Case report 23 July 2022 Pages: 37 - 37

38. Antiepileptics

    Case report 23 July 2022 Pages: 38 - 38

39. Antifungals/immunosuppressants

    Case report 23 July 2022 Pages: 39 - 39

40. Antineoplastic drugs

    Case report 23 July 2022 Pages: 40 - 40

41. Antineoplastics

    Case report 23 July 2022 Pages: 41 - 41

42. Antineoplastics

    Case report 23 July 2022 Pages: 42 - 42

43. Antineoplastics

    Case report 23 July 2022 Pages: 43 - 43

44. Antineoplastics

    Case report 23 July 2022 Pages: 44 - 44

45. Antineoplastics

    Case report 23 July 2022 Pages: 45 - 45

46. Antineoplastics

    Case report 23 July 2022 Pages: 46 - 46

47. Antineoplastics

    Case report 23 July 2022 Pages: 47 - 47

48. Antineoplastics

    Case report 23 July 2022 Pages: 48 - 48

49. Antineoplastics

    Case report 23 July 2022 Pages: 49 - 49

50. Antineoplastics

    Case report 23 July 2022 Pages: 50 - 50